Cefbuperazone
![]() | |
Systematic (IUPAC) name | |
---|---|
(6R,7S)-7-([(2R,3S)-2-[(4-Ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-3-hydroxybutanoyl]amino)-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Routes of administration | IM, IV |
Legal status |
|
Identifiers | |
CAS Number |
76610-84-9 ![]() |
ATC code | J01DC13 (WHO) |
PubChem | CID 127527 |
ChemSpider |
113142 ![]() |
UNII |
T0785J3X40 ![]() |
KEGG |
D03423 ![]() |
ChEMBL |
CHEMBL1908372 ![]() |
Chemical data | |
Formula | C22H29N9O9S2 |
Molar mass | 627.65 g/mol |
| |
| |
![]() ![]() |
Cefbuperazone (INN) is a second-generation cephalosporin antibiotic.[1][2]
References
- ↑ Izumi, K.; Kawazoe, K.; Mikamo, H.; Ito, K.; Tamaya, T. (1995). "In vivo bacterial regrowth-inhibition effect of cefbuperazone and amikacin in puerperal uterine cavity". Journal of chemotherapy (Florence, Italy). 7 Suppl 4: 173–176. PMID 8904147.
- ↑ US 4754030 "Cefbuperazone crystalline triethylamine salt"
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.